Status: Recruiting
Verifying Antibodies After Live Immunization Delivery (VALID): A Study of Measles Vaccine Immunogenicity in Children With Sickle Cell Disease
The goal of this study is to learn if infants with sickle cell disease (SCD) develop adequate protection after measles vaccines. (not looking at any prolonged duration)
Participants needed: 130
Trial details
Age: 6-6Biological sex: AllType: ObservationalSponsor: Children's Hospital Medical Center, CincinnatiUpdated: Jan 21, 2026Locations: 3
Eligibility criteria
Participants with confirmed Sickle Cell Disease. [+3]